A $1 per share special dividend was announced last month, and net sales were up more than 20% in its last quarter.ĭorchester Minerals LP (NASDAQ: DMLP) is limited partnership that basically is a land holder of producing and non-producing properties in the U.S. At a market cap of $67 million, growth will certainly move the stock price quickly.
And the expanding economy means heavy equipment sales should be expanding as well.ĮSP is up 17% year to date and it also has a solid 3.6% dividend. But now that the defense sector is spending again, big programs will boost business for ESP. And while that may limit its upside, it keeps its growth consistent in slow times. That makes it a key subcontractor on most military and industrial equipment. That means, if the military or say an industrial equipment maker needs reliable, heavy duty power supplies for its trucks, tanks or other machinery, it looks to ESP.
But once it does, you wonder why no one is talking about the stock.ĮSP has been testing, designing and manufacturing military and rugged industrial power supplies for more than 85 years. Either this small-cap continues to grow on its own, or a bigger player swoops in and takes it out at a premium.Įspey Manufacturing & Electronics Corporation (ESP)Įspey Manufacturing & Electronics Corporation (NYSEAMERICAN: ESP) is one of those companies that hardly hits anyone’s radar screen. population grays - about 10 million baby boomers are hitting 65 every year for the next 20 years - these are the kind of chronic conditions that they will need help and support with.Įven after the big selloff this week, IMMY is up 64% year to date and the best is yet to come. Having effective drugs that don’t cost consumers or insurers a lot of money is the perfect combination. The company also works with pharmacy benefit managers and healthcare insurers to make sure that its formularies don’t cost the patient too much.Īll this fits perfectly within the model of healthcare that the U.S. It focuses on the opthalmic formulations (pardon the pun). Compounded pharmaceuticals are drugs that are custom built for each particular patient. Imprimis Pharmaceuticals (NASDAQ: IMMY) is a San Diego-based pharmaceutical company that specializes in compounded pharmaceuticals.
These small-caps, and the sectors they represent, are more than ready for the next leg up in this market. These 10 small-caps with straight-A potential are well positioned to make the most out of this recovery. Interest rates are rising again and now portfolio managers are reallocating assets across stocks and bonds.Īnd at this point in a recovery, small-caps are especially attractive. What we’re seeing now is the ultimate success of that strategy for staving off that ruination. And no one knew if it was even going to work, much less how long it would last. Since the financial collapse, the Federal Reserve - and then other nations’ central banks - took off monetary policy to make sure there wasn’t a massive global financial collapse. And much of the bother this week was precisely because rates are no longer protected by the central banks, here or anywhere around the world. Large-caps, small-caps … everyone felt the pain.īut one thing is clear - interest rates are going up.
#Micro cap stocks with potential 2018 free#
Although, given the fact that most of the movement has been down, I’m not sure how much of a “ride” it has been - more of a free fall.
This week has certainly been a wild ride.
0 kommentar(er)
